All posts by: Michael Zand

About Michael Zand

Ohio diocese discourages ALS Association ice bucket challenge, cites … – Fox News

Continue reading

2014-08-21 NEWS

Fox News

Ohio diocese discourages ALS Association ice bucket challenge, cites
Fox News
CINCINNATI – A Catholic diocese in Ohio is discouraging its schools from participating in the ice bucket challenge to benefit the ALS Association, citing its funding of research involving embryonic stem cells. In a letter sent Tuesday to its 113
Cincinnati Archdiocese freezes Catholic school donations to ice bucket Washington Post (blog)
Archdiocese of Cincinnati douses enthusiasm for ice-bucket challenge in WCPO
Archdiocese: “We don’t support Ice Bucket Challenge for ALS” – WFSB 3 WFSB

all 32 news articles »

Continue reading

2014-08-21 NEWS

WOSU Public Media

Cancer Researchers Put Hope In Stem Cells
WOSU Public Media
All this week researchers from across the world gathered in Cleveland to attend Case Western Reserve University’s Cancer Stem Cell conference. For several years now, researchers have been kicking around a theory to explain how cancer operates in the …
Cancer Stem Cells May Be Key to Future Cancer Therapiesideastream
Case Western Reserve University hosts cancer stem cell conferenceWKSU News
Stem Cells 101 (or Stem Cells 702)ABC Online (blog)
DigitalJournal.com
all 8 news articles »
Continue reading

2014-08-21 NEWS

Proactive Investors Australia

Regeneus in stem cell manufacturing partnership with Cryosite
Proactive Investors Australia
Cryosite will provide production facilities for Regeneus’ off-the-shelf allogeneic stem cell product for human osteoarthritis (Progenza). The product, to be used for clinical trial purposes, will be manufactured within Cryosite’s good manufacturing

and more »

Continue reading

2014-08-21 NEWS

Proactive Investors Australia

Regeneus forms stem cell manufacturing partnership with Cryosite
Proactive Investors Australia
Cryosite will provide production facilities for Regeneus’ off-the-shelf allogeneic stem cell product for human osteoarthritis (Progenza). The product, to be used for clinical trial purposes, will be manufactured within Cryosite’s good manufacturing